Endocannabinoid chemical biology: a tool for the development of novel therapies
Authors:
- Stefania PetrosinoSPStefania Petrosino
- Alessia LigrestiALAlessia Ligresti
- Vincenzo Di MarzoVincenzo Di Marzo
- 1 June 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 13 (3) , 309-320
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- 2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in BrainBiochemical and Biophysical Research Communications, 1995
- Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptorsBiochemical Pharmacology, 1995
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Enantiomeric cannabinoids: stereospecificity of psychotropic activityCellular and Molecular Life Sciences, 1988
- Stereochemical requirements for cannabinoid activityJournal of Medicinal Chemistry, 1980
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964
- Hashish—ITetrahedron, 1963